Liwei Chen
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
-
- Cytokine Signaling Pathways and Interactions
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 3
- Cytokine Signaling Pathways and Interactions 2
- Cancer Cells and Metastasis 2
- Pancreatic and Hepatic Oncology Research 2
-
- Galectins and Cancer Biology 5
- Co-authors
- Jie Wu (8 shared papers)Harshani R. Lawrence (6 shared papers)Saı̈d M. Sebti (6 shared papers)Nicholas J. Lawrence (5 shared papers)Hua Bei Guo (6 shared papers)Yuchao He (5 shared papers)Wayne C. Guida (3 shared papers)Lisha Qi (4 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Cancer Letters (2 papers)Cancer Medicine (2 papers)Journal of Surgical Research (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Liwei Chen
37 papers receiving 792 citations
Peers
Comparison fields: 5 of 87
- Toxicology 44
- Oncology 214
- Cancer Research 104
- Immunology 145
- Molecular Biology 439
Countries citing papers authored by Liwei Chen
This map shows the geographic impact of Liwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Chen more than expected).
Fields of papers citing papers by Liwei Chen
This network shows the impact of papers produced by Liwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Chen. The network helps show where Liwei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Liwei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 86 | |
| 2 | 2005 | 81 | |
| 3 | 2022 | 67 | |
| 4 | 2019 | 62 | |
| 5 | 2017 | 59 | |
| 6 | 2010 | 40 | |
| 7 | 2015 | 38 | |
| 8 | 2010 | 34 | |
| 9 | 2012 | 33 | |
| 10 | 2021 | 28 | |
| 11 | 2012 | 28 | |
| 12 | 2020 | 26 | |
| 13 | 2020 | 26 | |
| 14 | 2023 | 23 | |
| 15 | 2015 | 18 | |
| 16 | 2020 | 16 | |
| 17 | 2022 | 16 | |
| 18 | 2023 | 15 | |
| 19 | 2012 | 13 | |
| 20 | 2022 | 13 |
About Liwei Chen
Liwei Chen is a scholar working on Oncology, Immunology, Molecular Biology, Cancer Research and Epidemiology, having authored 37 papers that have together received 816 indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (6 papers), Galectins and Cancer Biology (5 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer Cells and Metastasis (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Toxicology (44 citations), Oncology (214 citations), Cancer Research (104 citations), Immunology (145 citations) and Molecular Biology (439 citations). Liwei Chen has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Jie Wu, Harshani R. Lawrence, Saı̈d M. Sebti, Nicholas J. Lawrence, Hua Bei Guo, Yuchao He, Wayne C. Guida, Lisha Qi, Ning Zhang and Yunting Luo. Their work appears in journals such as Clinical Cancer Research, Cancer Letters, Cancer Medicine, Journal of Surgical Research and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.